仿制药基本盘要被撼动了？来源｜医药研究社四环医药医美业务扩张步伐未见放缓。据了解，在旗下渼颜空间生物科技（吉林）有限公司（以下简称“渼颜空间”）的注射用聚己内酯微球面部填充剂（PCL）、聚乳酸面部填充剂（PLLA）获得国家药监局批准后，四环医药正加紧推进相关产品上市。7月19日，该集团就将举办“不止”渼颜空间再生新品上市会，届时有聚乳酸、聚已内酯领域的4款再生材料新品亮相，表露出“不止于研发”的...
Source Link仿制药基本盘要被撼动了？来源｜医药研究社四环医药医美业务扩张步伐未见放缓。据了解，在旗下渼颜空间生物科技（吉林）有限公司（以下简称“渼颜空间”）的注射用聚己内酯微球面部填充剂（PCL）、聚乳酸面部填充剂（PLLA）获得国家药监局批准后，四环医药正加紧推进相关产品上市。7月19日，该集团就将举办“不止”渼颜空间再生新品上市会，届时有聚乳酸、聚已内酯领域的4款再生材料新品亮相，表露出“不止于研发”的...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.